1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Avalo Therapeutics Inc (AVTX)
  7. Quote

AVTX AVTX

Avalo Therapeutics Share Price - AVTX

Buy
Sell
0.90
0.0821 (10.04%)
Upgrade to Real-Time
Afterhours (Closed)
0.90
Volume 1,132,708
Bid Price 0.86
Ask Price 0.89
News -
Day High 0.93

Low
0.7812

52 Week Range

High
3.24

Day Low 0.8121
Best deals to access real time data!
USA Big Cap Pro
Monthly Subscription
for only
US$52.04
USA Small Cap Pro
Monthly Subscription
for only
US$49.05
DDE w/Realtime USA (Monthly)
Monthly Subscription
for only
US$34.10
VAT not included
Stock Name Stock Symbol Market Stock Type
Avalo Therapeutics Inc AVTX NASDAQ Common Stock
  Price Change Price Change % Stock Price Last Trade
0.0821 10.04% 0.90 09:41:34
Open Price Low Price High Price Close Price Previous Close
0.84 0.8121 0.93 0.8787 0.8179
Trades Stocks Traded VWAP Financial Volume Average Volume 52 Week Range
4,228 1,132,708 US$ 0.8679453 US$ 983,129 - 0.7812 - 3.24
Last Trade Type Quantity Price Currency
11:16:29 40 US$ 0.89 USD

Period:

Draw Mode:

Avalo Therapeutics Inc Financials
Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
US$ 101.09M 112.32M 72.32M US$ 6.70M US$ - -0.88 -1.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- US$ - - 205.42k 2.40%

more financials information »

Avalo Therapeutics News
Date Time Source News Article
21/1/202210:15Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
15/1/202209:50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
12/1/202210:19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
11/1/202219:32Seeking AlphaNew commercial chief at Avalo Therapeutics
11/1/202211:58GlobeNewswire Inc.Avalo Therapeutics Appoints Stephen Smolinski as Chief..
10/1/202212:55TipRanksAvalo Therapeutics (AVTX) Gets a Buy Rating from RBC Capital
07/1/202208:20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
07/1/202208:17Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)
07/1/202202:24Seeking AlphaAvalo Therapeutics discontinues multiple myeloma program;..
06/1/202223:56Edgar (US Regulatory)Current Report Filing (8-k)
06/1/202223:30GlobeNewswire Inc.Avalo Reports Positive Phase 1b Results for AVTX-002 in..
05/1/202208:28Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)

Historical AVTX Price Data
Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.96031.020.78120.8859258839,158-0.0603-6.28%
1 Month1.851.880.78121.17875,933-0.95-51.35%
3 Months2.322.450.78121.56502,059-1.42-61.21%
6 Months2.873.240.78121.97544,538-1.97-68.64%
1 Year2.873.240.78121.97544,538-1.97-68.64%
3 Years2.873.240.78121.97544,538-1.97-68.64%
5 Years2.873.240.78121.97544,538-1.97-68.64%
Your Recent History
NASDAQ
AVTX
Avalo Ther..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220123 03:11:55